Zydus Lifesciences Ltd

西德斯生命科学有限公司

on Monday announced the appointment of

周一宣布了任命

Swati Dalal

斯瓦蒂·达拉尔

as an additional director and

作为额外的董事和

Managing Director

总经理

of its wholly-owned arm

其全资子公司

Zydus Healthcare Ltd

西达斯医疗保健有限公司

.

。

The board of

董事会

Zydus Healthcare

瑞迪博士实验室

Ltd (ZHL) at its meeting held on June 16, 2025, approved the appointment of Swati Dalal as an additional director and the Managing Director of ZHL with effect from June 16, 2025, for five years, Zydus Lifesciences Ltd said in a regulatory filing.

有限公司（ZHL）在2025年6月16日举行的会议上批准任命斯瓦蒂·达拉尔为ZHL的额外董事兼董事总经理，自2025年6月16日起生效，任期五年，Zydus Lifesciences Ltd在一份监管文件中表示。

Dalal, whose last role was Managing Director of

达拉尔，其上一个角色是董事总经理

Abbott India Ltd

印度雅培有限公司

, has experience of over 30 years, the filing said.

，拥有超过30年的经验，申报文件显示。

She started her career with Wockhardt Nutrition and later joined erstwhile Boots. Through subsequent mergers with Knoll, Solvay and Abbott, she progressed in her career with various leadership roles across Abbott, including Commercial Director Sales & Marketing and Business Development & Commercial Excellence, among others..

她从沃克哈特营养公司开始了自己的职业生涯，后来加入了曾经的布茨公司。通过随后与克诺尔、索尔维和雅培的合并，她在雅培的职业生涯中担任了各种领导职务，包括商业销售与市场总监、业务发展与商业卓越总监等。

She is a graduate in pharmacy from PKM Kundnani College of Pharmacy, Mumbai and a post-graduate degree in

她毕业于孟买PKM Kundnani药学院的药学专业，并拥有

Management Studies

管理学研究

from Jamnalal Bajaj Institute of Management Studies in Mumbai, it added.

来自孟买的贾姆纳拉尔·巴贾杰管理研究学院，它补充道。

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报 WhatsApp 频道

)

)